CC Donnell, RL Walton, M Carrozzo - Oral Surgery, Oral Medicine, Oral …, 2021 - Elsevier
Pigmented oral mucosal lesions are diverse, and differential diagnosis can range from benign conditions such as oral melanotic macule to malignancies such as oral malignant …
N Pemmaraju, H Kantarjian, J Shan, E Jabbour… - …, 2012 - ncbi.nlm.nih.gov
Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy - PMC Back to Top Skip to main content NIH …
Objectives: This article reviews clinical experiences in the treatment of chronic myeloid leukemia (CML) in an environment of limited resources. Methods: We reviewed recent …
C Bosetti, T Rodríguez, L Chatenoud… - European Journal of …, 2011 - journals.lww.com
The objective of this study was to provide information on recent trends in cancer mortality in Mexico. We analyzed data provided by the World Health Organization, using joinpoint …
G De Massachusetts, B Israel, E UU… - Lancet …, 2013 - paliativossinfronteras.org
Las enfermedades no transmisibles, incluido el cáncer, están sobrepasando a las enfermedades infecciosas como la principal amenaza de salud en los países de ingresos …
J Cortes, L Huynh, E Mendelson, P Brandt… - Leukemia & …, 2020 - Taylor & Francis
Abstract Achievement of MR4. 5 (BCR-ABL1≤ 0.0032% on international scale) is an important goal of tyrosine kinase inhibitor (TKI) treatment for patients with chronic myeloid …
Purpose The main objective of this study is to gain a deeper understanding of how patients suffering from chronic myeloid leukemia (CML) cope with their illness. The study aims to …
J Ylescas‐Soria, AH de la Torre‐Lujan… - Cancer …, 2019 - Wiley Online Library
To determine potential predictors of long‐term survival in a large set of Hispanic (Mexican) patients with chronic myeloid leukemia (CML) treated with imatinib. We conducted an …
Purpose The purpose of this study was to evaluate the quality of life (QOL) of patients receiving treatment by the public health system in Brazil for chronic myeloid leukemia (CML) …